The FDA could significantly improve its decision-making processes by adopting AI-driven superforecasting methods. These advanced AI techniques can analyze vast datasets to predict the efficacy and safety of new drugs and medical devices with greater accuracy than current human-led evaluations. Implementing such a system would lead to faster approvals for beneficial treatments and quicker identification of potential risks, ultimately benefiting public health. AI
IMPACT Could accelerate drug approvals and improve safety assessments by leveraging advanced AI predictive capabilities.
RANK_REASON The item is an opinion piece discussing the potential application of AI to a regulatory body.
Read on Mastodon — sigmoid.social →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →